{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:37:42Z","timestamp":1781890662247,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007224","name":"Connaught Fund","doi-asserted-by":"publisher","award":["Connaught International Scholarship for doctoral students"],"award-info":[{"award-number":["Connaught International Scholarship for doctoral students"]}],"id":[{"id":"10.13039\/501100007224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Global Health"],"DOI":"10.1186\/s12992-025-01148-x","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:26:00Z","timestamp":1764318360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cIf I am here, it is because the system failed\u201d: a critical qualitative study of global commercial clinical trials for advanced cancer in Chile"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-6438","authenticated-orcid":false,"given":"Loreto","family":"Fern\u00e1ndez-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6626-6974","authenticated-orcid":false,"given":"Gary","family":"Rodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9908-8054","authenticated-orcid":false,"given":"Jorge","family":"Sapunar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-4358","authenticated-orcid":false,"given":"Amaya","family":"Perez-Brumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0314-5913","authenticated-orcid":false,"given":"Anne-Emanuelle","family":"Birn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"1148_CR1","unstructured":"European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures Key Data 2022. Accessed 8 December 2024. Available from: https:\/\/www.efpia.eu\/media\/637143\/the-pharmaceutical-industry-in-figures-2022.pdf"},{"key":"1148_CR2","doi-asserted-by":"crossref","unstructured":"Birn AE, Pillay Y, Holtz TH. Textbook of global health. Oxford University Press; 2017.","DOI":"10.1093\/acprof:oso\/9780199392285.001.0001"},{"key":"1148_CR3","doi-asserted-by":"crossref","unstructured":"Vuger AT, Separovic R, Tolaney SM, Trapani D. Globalization of clinical research in oncology: status, challenges, and future directions. J Cancer Policy. 2024 Aug;10:100500.","DOI":"10.1016\/j.jcpo.2024.100500"},{"key":"1148_CR4","unstructured":"C\u00e1mara de la Innovaci\u00f3n Farmac\u00e9utica. Recomendaciones para generar una pol\u00edtica de atracci\u00f3n de ensayos cl\u00ednicos. Accessed 8 December 2024. Available from: https:\/\/cifchile.cl\/wp-content\/uploads\/2024\/06\/ensayosClinicos-CIF-mayo2024-10MB.pdf"},{"key":"1148_CR5","unstructured":"Criteria Research. Experiencias e imaginarios en torno al sistema de salud. 2024."},{"key":"1148_CR6","unstructured":"Ministerio de salud. Plan Nacional de C\u00e1ncer 2022\u20132027. Accessed 8 December 2024. Available from: https:\/\/leydelcancer.minsal.cl\/documentos\/Marco-general-del-Plan-Nacional-de-Cancer-2022-2027.pdf"},{"key":"1148_CR7","unstructured":"Solimano A. Capitalismo a La chilena: y La prosperidad de Las \u00e9lites. Editorial Catalonia; 2018."},{"key":"1148_CR8","unstructured":"OECD, Health at a. Glance 2023: OECD Indicators. Accessed 9 December 2024. Available from: https:\/\/www.oecd.org\/en\/publications\/2023\/11\/health-at-a-glance-2023_e04f8239\/full-report\/component-80.html#indicator-d1e34216-1eb40c0900"},{"key":"1148_CR9","unstructured":"World Trade Organization. TRIPS \u2014 Trade-Related Aspects of Intellectual Property Rights. Accessed 9 December 2024. Available from: https:\/\/www.wto.org\/english\/tratop_e\/trips_e\/trips_e.htm"},{"key":"1148_CR10","doi-asserted-by":"crossref","unstructured":"Petryna A. When experiments travel: clinical trials and the global search for human subjects. Princeton University Press; 2009.","DOI":"10.1515\/9781400830824"},{"key":"1148_CR11","unstructured":"Prasad VK. Malignant: how bad policy and bad evidence harm people with cancer. JHU; 2020 Apr. p. 21."},{"key":"1148_CR12","doi-asserted-by":"crossref","unstructured":"Homedes N, Ugalde A, editors. Clinical trials in Latin america: where ethics and business clash. Springer International Publishing; 2014.","DOI":"10.1007\/978-3-319-01363-3"},{"key":"1148_CR13","unstructured":"United Language Group. 5 Reasons why Latin America is Great for Conducting Clinical Trials. Accessed 9 December 2024. Available from: https:\/\/www.unitedlanguagegroup.com\/blog\/global-news\/latin-america-clinical-trials"},{"key":"1148_CR14","unstructured":"HClinical. What Are the Benefits of Conducting Clinical Research in Latin America? Accessed 9 December 2024. Available from: https:\/\/hclinical.com\/what-are-the-benefits-of-conducting-clinical-research-in-latin-america\/"},{"key":"1148_CR15","unstructured":"Resolution Latin America. Why Latin America? Accessed 9 December 2024. Available from: https:\/\/resolutioncrs.com\/why-latin-america\/"},{"issue":"1","key":"1148_CR16","first-page":"391","volume":"2","author":"M Fern\u00e1ndez Pinto","year":"2019","unstructured":"Fern\u00e1ndez Pinto M. Doubly disadvantaged: on the recruitment of diverse subjects for clinical trials in Latin America. Tapuya: Latin Am Sci Technol Soc. 2019;2(1):391\u2013407.","journal-title":"Tapuya: Latin Am Sci Technol Soc"},{"key":"1148_CR17","unstructured":"Congressional Budget Office. Research and Development in the Pharmaceutical Industry. Accessed 9 December 2024. Available from: https:\/\/www.cbo.gov\/publication\/57126"},{"key":"1148_CR18","unstructured":"Code of Federal Regulations. 314.126 Adequate and well-controlled studies. Accessed 10 December 2024. Available from: https:\/\/www.ecfr.gov\/current\/title-21\/section-314.126"},{"key":"1148_CR19","unstructured":"World Medical Association. Declaration of Helsinki - \u2013 Ethical Principles for Medical Research Involving Human Participants. Accessed 10 December 2024. Available from: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki\/"},{"key":"1148_CR20","doi-asserted-by":"crossref","unstructured":"Hawkins JS, Emanuel EJ, eds. Exploitation and developing countries: the ethics of clinical research. Princeton University Press; 2008 Dec. p. 31.","DOI":"10.1515\/9781400837328"},{"issue":"2","key":"1148_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/17290376.2009.9724930","volume":"6","author":"K Mystakidou","year":"2009","unstructured":"Mystakidou K, Panagiotou I, Katsaragakis S, Tsilika E, Parpa E. Ethical and practical challenges in implementing informed consent in HIV\/AIDS clinical trials in developing or resource-limited countries. SAHARA: J Social Aspects HIV\/AIDS Res Alliance. 2009;6(2):46\u201357.","journal-title":"SAHARA: J Social Aspects HIV\/AIDS Res Alliance"},{"issue":"1","key":"1148_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12910-020-00530-1","volume":"21","author":"D Nyirenda","year":"2020","unstructured":"Nyirenda D, Sariola S, Kingori P, Squire B, Bandawe C, Parker M, Desmond N. Structural coercion in the context of community engagement in global health research conducted in a low resource setting in Africa. BMC Med Ethics. 2020;21(1):90.","journal-title":"BMC Med Ethics"},{"issue":"2","key":"1148_CR23","first-page":"1","volume":"48","author":"L Fernandez-Gonzalez","year":"2022","unstructured":"Fernandez-Gonzalez L, Valenzuela PB, Namias MR, Sepulveda D. Implementaci\u00f3n de Ensayos cl\u00ednicos y acceso Posensayo a vacunas Para La COVID-19 En Latinoam\u00e9rica. Revista Cubana De Salud P\u00fablica. 2022;48(2):1\u20132.","journal-title":"Revista Cubana De Salud P\u00fablica"},{"key":"1148_CR24","unstructured":"Keating P, Cambrosio A. Cancer on trial: oncology as a new style of practice. University of Chicago Press; 2019. Dec 31."},{"issue":"5","key":"1148_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","volume":"13","author":"DN Khalil","year":"2016","unstructured":"Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. The future of cancer treatment: immunomodulation, cars and combination immunotherapy. Nat Reviews Clin Oncol. 2016;13(5):273\u201390.","journal-title":"Nat Reviews Clin Oncol"},{"key":"1148_CR26","unstructured":"World Health Organization. WHO guideline on country pharmaceutical pricing policies. Accessed 16 July 2025. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240011878"},{"key":"1148_CR27","doi-asserted-by":"crossref","unstructured":"Brinkhuis F, Goettsch WG, Mantel-Teeuwisse AK, Bloem LT. High cost oncology drugs without proof of added benefit are burdening health systems. BMJ. 2024;384.","DOI":"10.1136\/bmj.q511"},{"key":"1148_CR28","unstructured":"National Cancer Institute. Pembrolizumab. Accessed 10 December 2024. Available from: https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/pembrolizumab"},{"key":"1148_CR29","unstructured":"Statista. Leading pharmaceutical products by sales worldwide in. 2023. Accessed 10 December 2024. Available from: https:\/\/www.statista.com\/statistics\/258022\/top-10-pharmaceutical-products-by-global-sales-2011\/"},{"issue":"5","key":"1148_CR30","doi-asserted-by":"publisher","first-page":"e193684","DOI":"10.1001\/jamanetworkopen.2019.3684","volume":"2","author":"A Addeo","year":"2019","unstructured":"Addeo A, Weiss GJ, Gyawali B. Association of industry and academic sponsorship with negative phase 3 oncology trials and reported outcomes on participant survival: a pooled analysis. JAMA Netw Open. 2019;2(5):e193684.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1148_CR31","first-page":"133","volume":"24","author":"T Godskesen","year":"2015","unstructured":"Godskesen T, Hansson MG, Nygren P, Nordin K, Kihlbom U. Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials. Eur J Cancer Care. 2015;24(1):133\u201341.","journal-title":"Eur J Cancer Care"},{"issue":"3","key":"1148_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/jnci\/djaa155","volume":"113","author":"JM Unger","year":"2021","unstructured":"Unger JM, Hershman DL, Till C, Minasian LM, Osarogiagbon RU, Fleury ME, Vaidya R. When offered to participate: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. JNCI: J Natl Cancer Inst. 2021;113(3):244\u201357.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"1148_CR33","doi-asserted-by":"crossref","unstructured":"Viljoen B, Chambers SK, Dunn J, Ralph N, March S. Deciding to enrol in a cancer trial: a systematic review of qualitative studies. J Multidisciplinary Healthc 2020 Oct 27:1257\u201381.","DOI":"10.2147\/JMDH.S266281"},{"key":"1148_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12904-020-00661-7","volume":"19","author":"M Murphy","year":"2020","unstructured":"Murphy M, McCaughan E, Carson MA, Donovan M, Wilson RH, Fitzsimons D. Nothing to lose: a grounded theory study of patients\u2019 and healthcare professionals\u2019 perspectives of being involved in the consent process for oncology trials with non-curative intent. BMC Palliat Care. 2020;19:1\u20130.","journal-title":"BMC Palliat Care"},{"issue":"2","key":"1148_CR35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/1467-9566.13424","volume":"44","author":"MS Dam","year":"2022","unstructured":"Dam MS, Green S, Bogicevic I, Hillersdal L, Spanggaard I, Rohrberg KS, Svendsen MN. Precision patients: selection practices and moral pathfinding in experimental oncology. Sociol Health Illn. 2022;44(2):345\u201359.","journal-title":"Sociol Health Illn"},{"key":"1148_CR36","doi-asserted-by":"crossref","unstructured":"Thallner R, Gumbinger C, Hohmann A, Wick A, Wick W, Busetto L, Patient. Relative and staff experiences of clinical trial participation in neurooncology:maybe you can also show the positive, no matter how it ends. Cancer Manage Res 2024 Dec 31:663\u201376.","DOI":"10.2147\/CMAR.S447407"},{"key":"1148_CR37","unstructured":"World Health Organization. Number of clinical trials by year, country, WHO region and income group. (1999\u20132024). Accessed 16 July 2025. Available from: https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-clinical-trials-by-year-country-who-region-and-income-group"},{"key":"1148_CR38","unstructured":"Instituto de Salud P\u00fablica. Estudios Cl\u00ednicos. Accessed 16 July 2025. Available from: https:\/\/www.ispch.gob.cl\/wp-content\/uploads\/2025\/03\/EC-autorizados-2019-2024.xlsx"},{"key":"1148_CR39","unstructured":"Buscador ensayos cl\u00ednicos CIF. Accessed 11 December 2024. Available from: https:\/\/estudiosclinicos.cl\/buscar-ensayos\/?cat=25"},{"key":"1148_CR40","doi-asserted-by":"crossref","unstructured":"Iskander R, Moyer H, Vigneault K, Mahmud SM, Kimmelman J. Survival benefit associated with participation in clinical trials of anticancer drugs: a systematic review and Meta-analysis. JAMA. 2024 May 20.","DOI":"10.1001\/jama.2024.6281"},{"key":"1148_CR41","unstructured":"World Bank Group. The World Bank in Chile. Accessed 11 December 2024. Available from: https:\/\/www.worldbank.org\/en\/country\/chile\/overview"},{"key":"1148_CR42","unstructured":"Robinson WI. Latin America and global capitalism: a critical globalization perspective. JHU; 2008 Nov. p. 24."},{"issue":"24","key":"1148_CR43","doi-asserted-by":"publisher","first-page":"16903","DOI":"10.3390\/ijerph192416903","volume":"19","author":"B Cabieses","year":"2022","unstructured":"Cabieses B, Esnouf S, Blukacz A, Espinoza MA, Mezones-Holguin E, Leyva R. Health in chile\u2019s recent constitutional process: a qualitative thematic analysis of civil proposals. Int J Environ Res Public Health. 2022;19(24):16903.","journal-title":"Int J Environ Res Public Health"},{"key":"1148_CR44","unstructured":"Universidad del Desarrollo. Estructura y funcionamiento del sistema de salud chileno. Accessed 16 July 2025. Available from: https:\/\/medicina.udd.cl\/centro-epidemiologia-politicas-salud\/files\/2019\/12\/ESTRUCTURA-Y-FUNCIONAMIENTO-DE-SALUD-2019.pdf"},{"key":"1148_CR45","unstructured":"C\u00e1mara de Diputadas y Diputados. Autoridades exponen situaci\u00f3n de listas de espera ante Comisi\u00f3n de Salud. Accessed 12 December 2024. Available from: https:\/\/www.camara.cl\/prensa\/prensa_cms.aspx?noticia=autoridades-exponen-situacion-de-listas-de-espera-ante-comision-de-salud"},{"key":"1148_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.socscimed.2013.04.034","volume":"99","author":"D Fassin","year":"2013","unstructured":"Fassin D. A case for critical ethnography. Rethinking the early years of the AIDS epidemic in South Africa. Soc Sci Med. 2013;99:119\u201326.","journal-title":"Soc Sci Med"},{"key":"1148_CR47","unstructured":"Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez. Estudios Cl\u00ednicos. Accessed 12 December 2024. Available from: https:\/\/www.falp.org\/landing\/uido-1\/"},{"key":"1148_CR48","unstructured":"Hammersley M, Atkinson P. Ethnography: principles in practice. 3rd ed. Routledge; 2007. London."},{"key":"1148_CR49","doi-asserted-by":"crossref","unstructured":"Emerson RM, Fretz RI, Shaw LL. Writing ethnographic fieldnotes. University of Chicago Press; 2011. Dec 25.","DOI":"10.7208\/chicago\/9780226206868.001.0001"},{"key":"1148_CR50","unstructured":"MinCiencia. Una oportunidad de repensar el conocimiento para Chile. Accessed 13 December 2024. Available from: https:\/\/www.minciencia.gob.cl\/noticias\/una-oportunidad-de-repensar-el-conocimiento-para-chil\/"},{"key":"1148_CR51","unstructured":"La Tercera. Ley Ricarte Soto: laboratorios suspenden estudios cl\u00ednicos para 1.328 pacientes. Accessed 13 December 2024. Available from: https:\/\/www.latercera.com\/diario-impreso\/ley-ricarte-soto-laboratorios-suspenden-estudios-clinicos-para-1328-pacientes\/"},{"issue":"1","key":"1148_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4067\/S0034-98872021000100110","volume":"149","author":"B Aguilera","year":"2021","unstructured":"Aguilera B. Tendencias En Ensayos cl\u00ednicos realizados En Chile. Revista M\u00e9dica De Chile. 2021;149(1):110\u20138.","journal-title":"Revista M\u00e9dica De Chile"},{"key":"1148_CR53","unstructured":"World Health Organization. WHA72.8. Improving the transparency of markets for medicines, vaccines, and other health products. Accessed 13 December 2024. Available from: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA72\/A72_R8-en.pdf"},{"key":"1148_CR54","unstructured":"BioBio Chile. Enfermedades raras y la urgencia de reformar el sistema de salud chileno. Accessed 13 December 2024. Available from: https:\/\/www.biobiochile.cl\/noticias\/opinion\/columnas-bbcl\/2024\/06\/23\/la-marcha-de-camila-gomez-y-las-deficiencias-del-sistema-de-salud-para-enfermedades-raras.shtml"},{"key":"1148_CR55","doi-asserted-by":"crossref","unstructured":"Biehl J. The Juridical hospital: claiming the right to pharmaceuticals in Brazilian courts. In: The clinic and the court: law, medicine and anthropology. Cambridge University Press. 2015 Jan 1 (pp. 163\u201396).","DOI":"10.1017\/CBO9781139923286.008"},{"key":"1148_CR56","unstructured":"C\u00e1mara de la Innovaci\u00f3n Farmac\u00e9utica. FIFARMA Lanza La Segunda versi\u00f3n Del informe W.A.I.T indicator Que Mide Los Tiempos de acceso a medicamentos innovadores En Latinoam\u00e9rica. Accessed 13 December 2024."},{"key":"1148_CR57","unstructured":"Fisher JA. Medical research for hire: the political economy of pharmaceutical clinical trials. Rutgers University Press; 2008. Nov 6."},{"key":"1148_CR58","doi-asserted-by":"crossref","unstructured":"Fisher JA. Adverse events: race, inequality, and the testing of new pharmaceuticals. In: Adverse events. New York University. 2020 May 12.","DOI":"10.18574\/nyu\/9781479877997.001.0001"},{"key":"1148_CR59","doi-asserted-by":"crossref","unstructured":"Dumit J. Drugs for life: how pharmaceutical companies define our health. Duke University Press; 2020. Dec 31.","DOI":"10.1515\/9780822393481"},{"key":"1148_CR60","doi-asserted-by":"crossref","unstructured":"Abadie R. The professional Guinea pig: big pharma and the risky world of human subjects. Duke University Press; 2010 Jul. p. 30.","DOI":"10.2307\/j.ctv11smqgx"},{"issue":"9","key":"1148_CR61","doi-asserted-by":"publisher","first-page":"e25769","DOI":"10.1002\/jia2.25769","volume":"24","author":"A Perez-Brumer","year":"2021","unstructured":"Perez-Brumer A, Naz-McLean S, Huerta L, Salazar X, Lama JR, Sanchez J, Silva-Santisteban A, Reisner SL, Mayer KH, Clark JL. The wisdom of mistrust: qualitative insights from transgender women who participated in PrEP research in lima, Peru. J Int AIDS Soc. 2021;24(9):e25769.","journal-title":"J Int AIDS Soc"},{"key":"1148_CR62","doi-asserted-by":"crossref","unstructured":"Araujo K. The circuit of detachment in chile: Understanding the fate of a neoliberal laboratory. Cambridge University Press; 2022 Aug.","DOI":"10.1017\/9781009310697"},{"key":"1148_CR63","unstructured":"Mayol A. El Derrumbe Del modelo: La crisis de La econom\u00eda de Mercado En El Chile contempor\u00e1neo. Editorial Catalonia; 2020."}],"container-title":["Globalization and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-025-01148-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12992-025-01148-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-025-01148-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T09:14:24Z","timestamp":1764666864000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalizationandhealth.biomedcentral.com\/articles\/10.1186\/s12992-025-01148-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1148"],"URL":"https:\/\/doi.org\/10.1186\/s12992-025-01148-x","relation":{},"ISSN":["1744-8603"],"issn-type":[{"value":"1744-8603","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was reviewed and approved by the Social Sciences, Humanities & Education Research Ethics Board (REB) of the University of Toronto (protocol #00041570), and the Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez Perez REB in Santiago, Chile (protocol #2021-037-PSY-SIN-INT), in accordance with the Declaration of Helsinki. All participants were informed about the details of the study before taking part and provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}